JOHN JOHNSON - 19 Dec 2024 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Signature
/s/ Leslie D. Funtleyder, as attorney-in-fact
Issuer symbol
APLT
Transactions as of
19 Dec 2024
Net transactions value
$0
Form type
4
Filing time
20 Dec 2024, 20:30:54 UTC
Previous filing
04 Sep 2024
Next filing
27 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +500,000 $0.000000 500,000 19 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Stock Option (Right to Buy) Award $0 +1,000,000 $0.000000 1,000,000 19 Dec 2024 Common Stock 1,000,000 $1.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units ("RSUs") granted outside of Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan pursuant to the inducement grant exception under Nasdaq Rule 5635(c). Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs will vest in equal annual installments on each of the first two anniversaries of the grant date, subject to the Reporting Person continuing to provide services through each such date.
F2 Consists of compensatory Options granted outside of Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan pursuant to the inducement grant exception under Nasdaq Rule 5635(c). The shares subject to the Option will vest in equal annual installments on each of the first two anniversaries of the grant date, subject to the Reporting Person continuing to provide services through each such date.